{
    "clinical_study": {
        "@rank": "88949", 
        "arm_group": {
            "arm_group_label": "Home and hospital treatment groups", 
            "description": "Patients were randomized into either home or hospital groups after a brief hospitalization(\u226424 hours. Hospital patients were followed 5 days in hospital.Home patients were visited on 2nd,3rd and 5th days by a staff nurse and the vital signs, symptoms, and general condition were recorded and transmitted back to the attending physician. On the 7th, 14th and 30th days, the home and hospital group patients were requested to return for a follow-up clinic visit at Bezmialem, at which time an assessment of their symptoms, physical examination, and laboratory evaluation was conducted."
        }, 
        "brief_summary": {
            "textblock": "Acute pancreatitis (AP) is considered a disease requiring in-hospital treatment. We studied\n      the feasibility of home management in AP.The aim of study was to compare 30 day readmission\n      rates in patients with mild non-alcoholic acute pancreatitis (NAAP) randomized to home\n      monitoring versus hospitalization."
        }, 
        "brief_title": "Home Treatment of Acute Pancreatitis", 
        "completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "condition": "Acute Pancreatitis", 
        "condition_browse": {
            "mesh_term": [
                "Pancreatitis", 
                "Pancreatitis, Chronic"
            ]
        }, 
        "detailed_description": {
            "textblock": "Between 11/11-5/12, 84 patients with mild NAAP were randomized to home or hospital groups\n      after a short (\u226424 hours) hospital stay. AP was defined as \u22652 or more of the following:\n      characteristic abdominal pain, amylase and/or lipase \u22653X the upper limit of normal, and/or\n      imaging findings. Patients with an Imrie's score \u22645 and a harmless acute pancreatitis score\n      (HAPS) \u22642 were included. Patients in both groups received intravenous lactated Ringer for 3\n      days and pain was treated with intramuscular diclofenac. A nurse visited all patients in the\n      home group on the 2nd, 3rd and 5th day. All patients recalled for follow-up on the 7th,\n      14th, and 30th days."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of AP based on 2 out of 3 findings: characteristic abdominal pain, amylase\n             and/or lipase levels \u22653 times the upper limit of normal, and/or abdominal imaging\n             demonstrating changes of acute pancreatitis\n\n          -  Presentation within 48 hours of symptom onset\n\n          -  Imrie's scores of \u22645 and HAP score \u22642 within 24 hours of presentation to the hospital\n\n          -  Lack of hemoconcentration (hematocrit \u226544%) on presentation since hemoconcentration\n             has been shown to be a risk factor for pancreatic necrosis.\n\n        Exclusion Criteria:\n\n          -  The presence of organ failure by the Atlanta criteria on the first day of\n             presentation\n\n          -  The presence of clinical signs and/or symptoms of sepsis\n\n          -  Alcoholic acute pancreatitis\n\n          -  A history of abdominal imaging demonstrating a dilated pancreatic duct and/or\n             pancreatic calcifications\n\n          -  Coagulopathy (international normalized ratio >1, and/or platelet count <50,000/mm3\n\n          -  Comorbidities requiring hospitalization regardless of the presence of AP e.g. acute\n             myocardial infarction, malignancy, cirrhosis, chronic kidney disease, and chronic\n             pulmonary disease)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Mild acute non-alhololic patients managed in home."
            }
        }, 
        "enrollment": {
            "#text": "84", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01796652", 
            "org_study_id": "B.30.2.BAV.0.05.05/374"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Acute interstitial pancreatitis", 
            "Home therapy"
        ], 
        "lastchanged_date": "February 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "\u0130stanbul", 
                    "country": "Turkey", 
                    "zip": "34093"
                }, 
                "name": "Bezmialem Vak\u0131f University Hospital, Gastroenterology Clinic"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Randomized Controlled Trial of Home Monitoring Versus Hospitalization in Mild Non-Alcoholic Acute Interstitial Pancreatitis", 
        "overall_official": {
            "affiliation": "Bezmialem Vak\u0131f University Hospital, Gastroenterology Clinic", 
            "last_name": "Hakan \u015eent\u00fcrk, Prof.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "30 day hospital readmission of home and hospital groups of patients were evaluated.", 
            "measure": "The primary outcome of the study was the 30 day hospital readmission rate.", 
            "safety_issue": "Yes", 
            "time_frame": "30 days"
        }, 
        "reference": [
            {
                "PMID": "20531398", 
                "citation": "Whitlock TL, Repas K, Tignor A, Conwell D, Singh V, Banks PA, Wu BU. Early readmission in acute pancreatitis: incidence and risk factors. Am J Gastroenterol. 2010 Nov;105(11):2492-7. doi: 10.1038/ajg.2010.234. Epub 2010 Jun 8."
            }, 
            {
                "PMID": "22153541", 
                "citation": "Rodr\u00edguez-Cerrillo M, Poza-Montoro A, Fernandez-Diaz E, I\u00f1urrieta-Romero A, Matesanz-David M. Home treatment of patients with acute cholecystitis. Eur J Intern Med. 2012 Jan;23(1):e10-3. doi: 10.1016/j.ejim.2011.07.012. Epub 2011 Aug 27."
            }, 
            {
                "PMID": "22470079", 
                "citation": "van Baal MC, Besselink MG, Bakker OJ, van Santvoort HC, Schaapherder AF, Nieuwenhuijs VB, Gooszen HG, van Ramshorst B, Boerma D; Dutch Pancreatitis Study Group. Timing of cholecystectomy after mild biliary pancreatitis: a systematic review. Ann Surg. 2012 May;255(5):860-6. doi: 10.1097/SLA.0b013e3182507646. Review."
            }, 
            {
                "PMID": "20954281", 
                "citation": "Andersson B, Pendse ML, Andersson R. Pancreatic function, quality of life and costs at long-term follow-up after acute pancreatitis. World J Gastroenterol. 2010 Oct 21;16(39):4944-51."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01796652"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Bezmialem Vakif University", 
            "investigator_full_name": "Ali T\u00fcz\u00fcn \u0130nce", 
            "investigator_title": "Asc Prof", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Elaboration time of abdominal pain in home and hospital group patients as hour from the admission time to ICU.\nTime to resumption of an oral diet measured from the time of presentation.", 
            "measure": "Other outcomes evaluated included the duration of abdominal pain and time to resumption of an oral diet, both measured in hours from the time of presentation.", 
            "safety_issue": "Yes", 
            "time_frame": "hours"
        }, 
        "source": "Bezmialem Vakif University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bezmialem Vakif University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "30 Days", 
        "verification_date": "February 2013"
    }
}